Weight loss drug and lifestyle program for breast cancer survivors
Treatments studied
This study tests whether a weekly injection called semaglutide, combined with a structured lifestyle program, can improve heart health in postmenopausal breast cancer survivors who are taking aromatase inhibitors. It may help reduce weight and lower the risk of heart problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with breast cancer after menopause (no periods for at least 12 months).
- Your breast cancer diagnosis was within the past 5 years and was stage 1, 2, or 3.
- You are between 46 and 55 years old.
- Your body mass index (BMI) is 30 or higher.
- You are currently taking an aromatase inhibitor.
- You are willing to learn to inject the medication yourself.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a GLP-1 agonist medication (like Ozempic) to help postmenopausal women lose weight and improve physical and blood vessel health. It focuses on women aged 46–60 with obesity.
This study compares different diets to see how they affect “arterial stiffness” (how hard the blood vessels are) in people with obesity who are starting semaglutide for weight management. It may help find a diet approach that improves heart and blood-vessel health while you use semaglutide.
This study tracks how semaglutide (an injectable medication that reduces appetite) helps adults lose weight in everyday life. Researchers want to understand how well it works and how safe it is for people starting the treatment.
This study tests a medication called semaglutide (which helps with weight loss) in people with obesity who have struggled to lose weight before. It will see how much weight participants can lose while taking the drug.
This trial tests if semaglutide (a weekly injection) helps people who lost less weight than expected after gastric bypass or sleeve surgery. It's for patients who had a high BMI before surgery and are in a special support program.
This study tests if a medication called semaglutide can help people with obesity lose weight by changing the bacteria in their gut. You may be able to join if you have obesity, have tried to lose weight before, and are generally healthy.
Hear when a new Anatomic Stage I Breast Cancer AJCC v8 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.